Literature DB >> 15531734

Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.

Ichiro Nomura1, Jun Abe, Seiji Noma, Hirohisa Saito, Bifeng Gao, Gary Wheeler, Donald Y M Leung.   

Abstract

Kawasaki disease (KD) is an acute inflammatory disorder of children frequently associated with the development of coronary artery abnormalities. Although a great deal is known about inflammatory and immune responses in acute KD, the mechanisms linking the immune response to vascular changes are not known. To gain further insight into this process, we performed a microarray gene expression analysis on RNA isolated from the peripheral blood mononuclear cells of four patients with KD during both their acute and convalescent phases. Forty-seven genes of 7129 genes examined showed an increased expression in three or all four patients in the acute compared with the convalescent phase of KD. Fourteen of these genes were significantly (p < 0.05) up-regulated, including several inflammatory response genes (e.g. S-100 A9 protein) and also anti-inflammatory genes (e.g. TSG-6). Of greatest interest, the adrenomedullin (ADM) gene, known to be associated with coronary artery vasodilation, was up-regulated in the acute phase of KD (p = 0.024). Up-regulation of ADM in the acute phase of KD was confirmed in peripheral blood mononuclear cells of 11 additional KD patients by reverse transcriptase-PCR (p < 0.01). Isolated blood monocytes but not lymphocytes were demonstrated by real-time PCR to have increased ADM mRNA (p = 0.01). Plasma ADM protein level in 32 additional KD patients was also confirmed to be higher in acute KD compared with convalescent KD (p < 0.032). It is interesting that from microarray results, other molecules known to be associated with coronary dilation, including nitric oxide, prostacyclin, acetylcholine, bradykinin, substance P, and serotonin, were not elevated in acute KD. Our current study suggests that ADM-expressing monocytes that infiltrate the coronary vascular wall may be the cause of coronary dilation in the acute phase of KD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531734     DOI: 10.1203/01.PDR.0000147745.52711.DD

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.

Authors:  Wen Fury; Adriana H Tremoulet; Virginia E Watson; Brookie M Best; Chisato Shimizu; Jennifer Hamilton; John T Kanegaye; Yi Wei; Chiayi Kao; Scott Mellis; Calvin Lin; Jane C Burns
Journal:  Hum Immunol       Date:  2010-06-20       Impact factor: 2.850

2.  The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease.

Authors:  Ming-Guo Xu; Li-Na Men; Chun-Yu Zhao; Xia Zhao; Yuan-Xiang Wang; Xiang-Chun Meng; Ding-Rong Shen; Bao-Ying Meng; Qing Zhang; Tao Wang
Journal:  Eur J Pediatr       Date:  2009-06-23       Impact factor: 3.183

3.  Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease.

Authors:  Long Truong Hoang; Chisato Shimizu; Ling Ling; Ahmad Nazri Mohamed Naim; Chiea Chuen Khor; Adriana H Tremoulet; Victoria Wright; Michael Levin; Martin L Hibberd; Jane C Burns
Journal:  Genome Med       Date:  2014-11-20       Impact factor: 11.117

4.  Diagnostic model based on bioinformatics and machine learning to distinguish Kawasaki disease using multiple datasets.

Authors:  Mengyi Zhang; Bocuo Ke; Huichuan Zhuo; Binhan Guo
Journal:  BMC Pediatr       Date:  2022-08-30       Impact factor: 2.567

5.  Gene-expression patterns reveal underlying biological processes in Kawasaki disease.

Authors:  Stephen J Popper; Chisato Shimizu; Hiroko Shike; John T Kanegaye; Jane W Newburger; Robert P Sundel; Patrick O Brown; Jane C Burns; David A Relman
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

6.  Diagnostic Value of Immune-Related Genes in Kawasaki Disease.

Authors:  Dong Liu; Meixuan Song; Fengchuan Jing; Bin Liu; Qijian Yi
Journal:  Front Genet       Date:  2021-12-10       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.